Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Frontiers in Drug Delivery|June 19, 2026
Phosphosulindac (OXT-328) restores the suppressed corneal sensitivity in rabbits with dry eye disease: therapeutic implicationsWei Huang, Ziyi Wen, Konstantinos Tourmouzis, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|December 29, 2021
Once-Daily Topical Phosphosulindac Is Efficacious in the Treatment of Dry Eye Disease: Studies in Rabbit Models of Its Main Clinical SubtypesWei Huang, Liqun Huang, Wenyi Li, et al.American Journal of Ophthalmology Case Reports|April 11, 2024
Unilateral conjunctival Classic Kaposi Sarcoma following a COVID 19 boosterEmily White, Nicholas Fazio, Konstantinos Tourmouzis, et al.Plos One|July 29, 2021
The transcriptome of rabbit conjunctiva in dry eye disease: Large-scale changes and similarity to the human dry eyeAdam Master, Apostolos Kontzias, Liqun Huang, et al.International Journal of Pharmaceutics|January 1, 2019
The ocular pharmacokinetics and biodistribution of phospho-sulindac (OXT-328) formulated in nanoparticles: Enhanced and targeted tissue drug deliveryZiyi Wen, Natsuko Muratomi, Wei Huang, et al.Current Eye Research|August 11, 2025
Monitoring the Evolution of Dry Eye Disease in Rabbits with Advanced Ocular Keratography: Implications for Translational StudiesNicholas Fazio, Emily White, Konstantinos Tourmouzis, et al.Clinical Ophthalmology (Auckland, N.Z.)|November 3, 2025
Comparative Performance of Artificial Tear Drops Assessed with Objective Non-Invasive ImagingEmily Rose White, Ishan Amin Khwaja, Nicholas Fazio, et al.Frontiers in Neuroscience|February 13, 2024
Phosphosulindac (OXT-328) prevents and reverses chemotherapy induced peripheral neuropathy in miceAryah Basu, Jennifer Y Yang, Vasiliki E Tsirukis, et al.Human Molecular Genetics|October 11, 2019
ADAMTS9 and ADAMTS20 are differentially affected by loss of B3GLCT in mouse model of Peters plus syndromeBernadette C Holdener, Christopher J Percival, Richard C Grady, et al.Pageof 3